Maggie Fader
Pediatric Hematology-Oncology · Miami, FLNPI 1609025915
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (38.1%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Y-mabs Therapeutics, Inc. accounts for 64.1% of it on its own, with 22 other manufacturers making up the rest. 2025 is the largest year on record at $6,026, more than ten times the $122 reported in 2019.
Across 79 payments — averaging $142.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Y-mabs Therapeutics, Inc.$7K
- Bayer$1K
- Sobi, Inc$538
- AstraZeneca$430
- USWM, LLC$287
- Astellas Pharma US Inc$241
- plus $1K from 17 others
Across 62 payments — averaging $1673.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$62K
- Pfizer$42K
What the payments were for
- Consulting fees$4,30338%
- Speaking & faculty fees$3,16328%
- Food & beverage$3,74133%
- Education$841%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Y-mabs Therapeutics, Inc. | 14 | $7,243 |
| Bayer | 5 | $1,403 |
| Sobi, Inc | 8 | $538 |
| AstraZeneca(2 entities) | 5 | $430 |
| USWM, LLC | 4 | $287 |
| Astellas Pharma US Inc | 5 | $241 |
| Amgen | 3 | $155 |
| Novartis | 8 | $150 |
| Sanofi | 2 | $150 |
| Sanofi-aventis U.S. LLC | 1 | $150 |
| Novo Nordisk | 5 | $119 |
| Genentech USA, Inc. | 4 | $82 |
| Genetix Biotherapeutics Inc | 1 | $52 |
| Agios Pharmaceuticals, Inc. | 3 | $50 |
| Springworks Therapeutics, Inc. | 2 | $41 |
| HEMA Biologics, LLC | 2 | $33 |
| Pfizer | 1 | $32 |
| Octapharma USA, Inc. | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Servier Pharmaceuticals LLC | 1 | $24 |
| Day One Biopharmaceuticals | 1 | $23 |
| Emmaus Medical, Inc. | 1 | $19 |
| Biomarin Pharmaceutical Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,291 in reported general payments places this provider in the 85th percentile of 132 pediatric hematology-oncology providers in Florida.
See all pediatric hematology-oncology providers in Florida →
Other pediatric hematology-oncology in Miami
- Guillermo DeanguloMiami$929K
- Joanna DavisMiami$411K
- Fernando Corrales-MedinaMiami$335K
- Rachel KronenfeldMiami$40K
- Ofelia AlvarezMiami$9K
- Julio BarredoMiami$8K
- Jorge Galvez SilvaMiami$7K
- Ossama MaherMiami$6K
- Sasha InclanMiami$5K
- Ziad KhatibMiami$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.